Inari Medical Stock (NASDAQ:NARI)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$54.41

52W Range

$36.73 - $66.61

50D Avg

$49.64

200D Avg

$46.69

Market Cap

$3.25B

Avg Vol (3M)

$928.50K

Beta

0.96

Div Yield

-

NARI Company Profile


Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism. It also offers FlowSaver; FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

1,300

IPO Date

May 22, 2020

Website

NARI Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 23Dec 22
UNITED STATES$469.86M$374.04M
Non-US$23.77M$9.43M

Fiscal year ends in Dec 23 | Currency in USD

NARI Financial Summary


Dec 23Dec 22Dec 21
Revenue$493.63M$383.47M$276.98M
Operating Income$-14.03M$-28.10M$6.67M
Net Income$-1.64M$-29.27M$9.84M
EBITDA$-14.03M$-18.77M$10.98M
Basic EPS$-0.03$-0.55$0.20
Diluted EPS$-0.03$-0.55$0.18

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q3 24Oct 28, 24 | 8:16 PM
Q2 24Jul 30, 24 | 9:53 PM
Q1 24Apr 30, 24 | 12:00 AM

Peer Comparison


TickerCompany
AXNXAxonics, Inc.
LEGNLegend Biotech Corporation
PGNYProgyny, Inc.
OMOutset Medical, Inc.